Benlysta (belimumab)

pCPA File Number: 21220
Negotiation Status:
Concluded with an LOI
Indication(s):
Systemic lupus erythematosus
Sponsor/Manufacturer:
GlaxoSmithKline Inc.
CDA-AMC Project Number:
SR0616
pCPA Engagement Letter Issued:
Negotiation Process Concluded: